Ces radiol. 2015, 69(2):129-136 | DOI: 10.55095/CesRadiol2015/020

Transcathetral arterial chemoembolization of the liver - technical problems and complicationsReview article

Jakub Hustý, Jaroslav Boudný, Vlastimil Válek, Tomáš Andrašina
Radiologická klinika Lékařské fakulty Masarykovy univerzity a FN, Brno

Transcathetral arterial chemoembolization of the liver (TACE) plays important role in management of selected liver tumours nowdays. The technique is similar to other embolization procedures, nevertheless besides general it is also associated with specific technical problems and complications.
Technical problems are represented by technical difficulties of catheterization (stenosis, anatomical variants, etc.), occurence of dissections or spasms, presence of extra hepatic collateral supply and occurence of arterioportal or arterivenous shunts.
Specific complications include nontarget embolization of arteries supplying surrounding organs (gallbladder, gastroduodenum), development of liver abscess or liver failure.
The knowledge of potential complications and technical problems of TACE can significantly improve the outcome of patients indicated to this procedure.

Keywords: chemoembolization, complications, liver
Grants and funding:

Práce vznikla v rámci projektu MUNI/A/1001/2013 Grantové agentury MU.

Accepted: April 14, 2015; Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hustý J, Boudný J, Válek V, Andrašina T. Transcathetral arterial chemoembolization of the liver - technical problems and complications. Ces radiol. 2015;69(2):129-136. doi: 10.55095/CesRadiol2015/020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Válek V, a kol. Maligní ložiskové procesy jater - diagnostika a léčba včetně minimálně invazivních metod. Praha: Grada Publishing 2006.
    2. Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol 2012; 35(4): 765-774. Go to original source... Go to PubMed...
    3. Sueyoshi E, Hayashida T, Sakamoto I, Uetani M. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2010; 195(1): 245-251. Go to original source... Go to PubMed...
    4. López-Benítez R, et al. Analysis of nontarget embolization mechanisms during embolization and chemoembolization procedures. Cardiovasc Intervent Radiol 2009; 32(4): 615-622. Go to original source... Go to PubMed...
    5. Gates J, Hartnell GG, Stuart KE, Clouse ME. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 1999; 19(2): 399-414. Go to original source... Go to PubMed...
    6. Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS. Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics 2002; 22(5): 1077-1091. Go to original source... Go to PubMed...
    7. Vogl TJ, et al. Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma. World J Gastroenterol 2011; 17(10): 1267-1275. Go to original source... Go to PubMed...
    8. Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol 2002; 3(1): 1-15. Review. Go to original source... Go to PubMed...
    9. Huang MS, et al. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(6): 825-829. Go to original source... Go to PubMed...
    10. Ngan H, Peh WC. Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol 1997; 52(1): 36-40. Go to original source... Go to PubMed...
    11. Senokuchi T, Baba Y, Hayashi S, Nakajo M. Embolization of hepatic arteriovenous shunt with absolute ethanol in a patient with hepatocellular carcinoma. Cardiovasc Intervent Radiol 2011; 34(Suppl 2): S154-156. Go to original source... Go to PubMed...
    12. Lee JH, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein. J Vasc Interv Radiol 2007; 18(3): 377-382. Go to original source... Go to PubMed...
    13. Castells A, et al. Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 1995; 22(4): 410-415. Go to original source... Go to PubMed...
    14. Brown DB, et al. Society of Interventional Radiology Standards of Practice Committee.Quality improvement guidelines for transhepatic arterial chemoembolization,embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2012; 23(3): 287-294. Go to original source... Go to PubMed...
    15. Chan AO, et al. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002; 94(6): 1747-1752. Go to original source... Go to PubMed...
    16. Marelli L et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30(1): 6-25. Go to original source... Go to PubMed...
    17. Vanderwalde AM, Marx H, Leong L. Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations. Gastrointest Cancer Res 2009; 3(6): 247-251.
    18. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12(8): 965-968. Go to original source... Go to PubMed...
    19. Plentz RR, et al. Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy. J Gastroenterol Hepatol 2005; 20(7): 1134-1136. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content